Contact
Please use this form to send email to PR contact of this press release:
Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
TO:
Please use this form to send email to PR contact of this press release:
Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
TO: